ziprasidone has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Goto, S; Karube, Y; Koga, M; Matsunaga, K; Murata, A; Setoguchi, S; Takata, J; Terada, K; Toki, E; Watase, D; Yamakawa, H | 1 |
1 other study(ies) available for ziprasidone and Electron Transport Chain Deficiencies, Mitochondrial
Article | Year |
---|---|
Atypical Antipsychotic Drug Ziprasidone Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study.
Topics: Animals; Antioxidants; Antipsychotic Agents; Apoptosis; Cell Death; Cell Nucleus; Cell Survival; Cytoplasm; Mice; Mitochondrial Diseases; Nerve Growth Factor; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Piperazines; Rats; Reactive Oxygen Species; Receptor, Serotonin, 5-HT1A; Rotenone; Thiazoles | 2020 |